Here's a look at some of the stories that made the news this week.Predictive Discovery – Argo and Bokoro Permits Revoked (28 ...

Which companies developing cancer drugs are attractive takeover targets? Seeking Alpha analysts offer their picks. Read more here.

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

Introduction Oncology drugs are medications used to prevent or treat cancer. These include chemotherapy, targeted therapy, immunotherapy, and h ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Stocks of cancer treatment developers will be moving into the spotlight later this week when the annual meeting of the ...

Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...

START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...